BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 18, 2025
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
March 31, 2016
View Archived Issues
Start-up Medicortex taking on TBI in dual drug-biomarker approach
Read More
Fujifilm developing photo technology into regenerative therapy
Read More
Upton: Is U.S. prepared to test millions of pregnant women for Zika?
Read More
Other news to note
Read More
Daily M&A
Read More
Appointments and advancements
Read More
Financings
Read More
product briefs
Read More
MDD's Orthopedics Extra
Read More
Diasorin to acquire Focus assets from Quest Diagnostics for $300 million
Saluggia, Italy-based, Diasorin S.p.A. said it will acquire Focus Diagnostics Inc.'s immunodiagnostic and molecular diagnostic products for $300 million in cash from Madison, N.J.-based, Quest Diagnostics Inc.
Read More
House members prod CMS to delay lab fee overhaul until 2018
Read More
